Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131905) titled 'A Prospective, Open-Label, Single-Arm, Phase Ib/II Study of Neoadjuvant Propranolol Combined With SOX Chemotherapy and Toripalimab in Patients With Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma' on Sept. 7.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Resectable Locally Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
Recruitment Status: Not Recruiting
Phase: 1-2
Date of First Enrollment: 2026-09-07
Target Sample Size: Intervention Group:49;
Countries of Re...